Next Article in Journal
Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
Next Article in Special Issue
N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
Previous Article in Journal
Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
Previous Article in Special Issue
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development
 
 
Article

Article Versions Notes

Vaccines 2020, 8(2), 199; https://doi.org/10.3390/vaccines8020199
Action Date Notes Link
article xml file uploaded 26 April 2020 15:51 CEST Original file -
article pdf uploaded. 26 April 2020 15:51 CEST Version of Record https://www.mdpi.com/2076-393X/8/2/199/pdf-vor
article supplementary file uploaded. 26 April 2020 15:51 CEST - https://www.mdpi.com/2076-393X/8/2/199#supplementary
article xml file uploaded 30 April 2020 10:25 CEST Update -
article xml uploaded. 30 April 2020 10:25 CEST Update https://www.mdpi.com/2076-393X/8/2/199/xml
article pdf uploaded. 30 April 2020 10:25 CEST Updated version of record https://www.mdpi.com/2076-393X/8/2/199/pdf
article html file updated 30 April 2020 10:27 CEST Original file -
article html file updated 7 July 2020 08:48 CEST Update -
article html file updated 21 July 2022 03:06 CEST Update https://www.mdpi.com/2076-393X/8/2/199/html
Back to TopTop